Prioritizing genetic testing in patients with kallmann syndrome using clinical phenotypes.


Autoria(s): Costa-Barbosa F.A.; Balasubramanian R.; Keefe K.W.; Shaw N.D.; Al-Tassan N.; Plummer L.; Dwyer A.A.; Buck C.L.; Choi J.H.; Seminara S.B.; Quinton R.; Monies D.; Meyer B.; Hall J.E.; Pitteloud N.; Crowley W.F.
Data(s)

2013

Resumo

Context: The complexity of genetic testing in Kallmann syndrome (KS) is growing and costly. Thus, it is important to leverage the clinical evaluations of KS patients to prioritize genetic screening. Objective: The objective of the study was to determine which reproductive and nonreproductive phenotypes of KS subjects have implications for specific gene mutations. Subjects: Two hundred nineteen KS patients were studied: 151 with identified rare sequence variants (RSVs) in 8 genes known to cause KS (KAL1, NELF, CHD7, HS6ST1, FGF8/FGFR1, or PROK2/PROKR2) and 68 KS subjects who remain RSV negative for all 8 genes. Main Outcome Measures: Reproductive and nonreproductive phenotypes within each genetic group were measured. Results: Male KS subjects with KAL1 RSVs displayed the most severe reproductive phenotype with testicular volumes (TVs) at presentation of 1.5 ± 0.1 mL vs 3.7 ± 0.3 mL, P < .05 vs all non-KAL1 probands. In both sexes, synkinesia was enriched but not unique to patients with KAL1 RSVs compared with KAL1-negative probands (43% vs 12%; P < .05). Similarly, dental agenesis and digital bone abnormalities were enriched in patients with RSVs in the FGF8/FGFR1 signaling pathway compared with all other gene groups combined (39% vs 4% and 23% vs 0%; P < .05, respectively). Hearing loss marked the probands with CHD7 RSVs (40% vs 13% in non-CHD7 probands; P < .05). Renal agenesis and cleft lip/palate did not emerge as statistically significant phenotypic predictors. Conclusions: Certain clinical features in men and women are highly associated with genetic causes of KS. Synkinesia (KAL1), dental agenesis (FGF8/FGFR1), digital bony abnormalities (FGF8/FGFR1), and hearing loss (CHD7) can be useful for prioritizing genetic screening.

Identificador

http://serval.unil.ch/?id=serval:BIB_A457B2246597

isbn:1945-7197 (Electronic)

pmid:23533228

doi:10.1210/jc.2012-4116

isiid:000318688200020

Idioma(s)

en

Fonte

Journal of Clinical Endocrinology and Metabolism, vol. 98, no. 5, pp. E943-E953

Tipo

info:eu-repo/semantics/article

article